通化金马：新药在审评过程中出现暂停等情形正常状态

Core Viewpoint - Tonghua Golden Horse (000766) is currently undergoing a normal review process for its new drug, indicating that pauses during the review are a standard part of the drug evaluation process [1] Group 1 - The company is actively communicating with the Center for Drug Evaluation (CDE) and responding to relevant materials during the review process [1]